Ensembl
Ensembl is a public, open-access genome browser operated by EMBL-EBI providing annotated genomic data and analysis tools for over 4,700 species to global academic, biotech, and clinical research communities at no cost.
- Company typePrivate
- Founded1999
- HeadquartersHinxton, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Ensembl does
Ensembl is a public research infrastructure project providing open access to genomic data, annotations, and analysis tools for over 4,700 species. Operated by the European Bioinformatics Institute (EMBL-EBI) since 1999 and based in Hinxton, United Kingdom, Ensembl serves academic researchers, pharmaceutical and biotech scientists, and clinical geneticists as a centralized, freely accessible alternative to fragmented public genome resources.
The core offering is the Ensembl Genome Browser, a web-based platform that delivers consistent, standardized annotations across vertebrates, plants, fungi, protists, and metazoa, with unique pangenome assets (565 human haplotypes, 69 barley cultivars, 27 pig breeds, and 30-pig EPO-Extended comparative alignment). Supporting tools include BioMart for data mining and dataset export, BLAST/BLAT for sequence similarity search, and the Variant Effect Predictor (VEP) for variant consequence analysis. Programmatic access is provided via REST APIs, and the platform is currently being transitioned from the legacy interface to a new unified site at beta.ensembl.org, consolidating ~36,000 prokaryotic genomes alongside eukaryotic data by July 2026.
Ensembl generates no commercial revenue. The platform is entirely free, funded through EMBL-EBI's institutional and governmental support, and distributed via self-serve web access with no sales motion. Governance sits within the EMBL-EBI nonprofit research infrastructure rather than a venture-backed or publicly traded entity, and the project operates as mission-driven public infrastructure serving the global scientific community.
Ensembl firmographics
Firmographics- Name
- Ensembl
- Legal name
- Ensembl (European Bioinformatics Institute, EMBL-EBI)
- Website
- https://asia.ensembl.org
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Ensembl is a public, open-access genome browser operated by EMBL-EBI providing annotated genomic data and analysis tools for over 4,700 species to global academic, biotech, and clinical research communities at no cost.
- Ownership category
- akta.pro rank
Ensembl industry classification
Industry- Product category
- Genomics Bioinformatics Platform
- NAICS
- Software Publishers (5132), Web Search Portals and All Other Information Services (519290)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where Ensembl is headquartered
LocationHeadquarters
- HQ city
- Hinxton
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Ensembl business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Free Public Access: Ensembl is entirely free and open access, funded by government/institutional research funding through EMBL-EBI. There is no commercial revenue generation; the platform is maintained as a public scientific resource.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free tier - all features available to all users |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Ensembl product offering
Product offeringCore offering
Ensembl provides a free, web-based genome browser platform delivering integrated reference genomes, annotations, and analysis tools for over 4,700 species, including human, mouse, zebrafish, plants, fungi, protists, and prokaryotes. Researchers access interactive visualization, sequence similarity search (BLAST/BLAT), variant functional annotation (VEP), and data mining/export (BioMart), with both web UI and REST API access. The platform is operated by EMBL-EBI as a public research infrastructure, serving academic scientists, pharmaceutical researchers, and clinical geneticists worldwide.
Product overview
Ensembl is a public and open genomics project providing a unified platform for accessing genome data. The core offering consists of the Ensembl Genome Browser, which provides integrated access to genome annotations, tools, and data. Supporting tools include BioMart (data mining/export), BLAST/BLAT (sequence search), and the Variant Effect Predictor (VEP) for variant analysis. The organization is transitioning to a new platform (beta.ensembl.org) which will consolidate all data and tools, including the migration of prokaryotic genomes (~36,000) from sister sites (Ensembl Bacteria, Fungi, Plants, Protists, Metazoa) by July 2026.
Differentiator
Problem solved
Functional benefit
Products and services
- Ensembl Genome Browser Web-based interactive genome browser providing integrated access to reference genomes, gene annotations, and comparative genomic data across 4,700+ species for the global research community. Used by academic, pharmaceutical, and clinical researchers to explore genomic regions, view gene structures, and access cross-species comparisons.
- BioMart Data-mining tool that enables researchers to export custom datasets from Ensembl databases using advanced filtering and query interfaces, supporting retrieval of gene, variation, and cross-species data subsets. Used by researchers needing batch genomic data extraction.
- BLAST/BLAT Sequence similarity search tool that lets users submit DNA or protein sequences and search for homologous sequences across Ensembl genomes. Used by molecular biologists performing sequence-based lookups against the Ensembl reference collection.
- Variant Effect Predictor (VEP) Tool that analyzes user-provided genetic variants (known and unknown) and predicts their functional consequences on genes, transcripts, and protein sequences. Used by clinical geneticists, pharmaceutical researchers, and academic scientists for variant interpretation and prioritization.
- New Ensembl Platform (beta.ensembl.org) Next-generation Ensembl platform providing consolidated access to over 4,700 genomes including pangenomes and migrated prokaryotic data, replacing the current useast.ensembl.org site as the primary Ensembl destination from summer 2026. Used by the same research community as a more modern, unified browser and API environment.
Quantifiable outcome
- Reference resource for over 4700 species genomes accessible to global research community
Companies that use Ensembl
Customer profileSegments3 records
Ideal customer profiles3 records
Ensembl technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Ensembl partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- EMBL-EBI (European Molecular Biology Laboratory, European Bioinformatics Institute)coreEnsembl is based at and operated by EMBL-EBI, a leading European bioinformatics research institute. This provides institutional backing, long-term sustainability, and integration with other EBI resources and services. EMBL-EBI provides funding, infrastructure, and personnel support for Ensembl operations.
- ELIXIRcoreEnsembl is part of the ELIXIR European research infrastructure for biological data. ELIXIR coordinates bioinformatics resources across Europe and provides strategic support for data standards and interoperability.
- Global BioData InitiativeminorEnsembl participates in the Global BioData Initiative aimed at building global infrastructure for biological data resources to support life science research worldwide.
- Darwin Tree of Life ProjectcoreGenomes from the Darwin Tree of Life project are regularly added to Ensembl, supporting the goal of sequencing all eukaryotic species in Britain and Ireland.
- Human Pangenome Reference ConsortiumcoreEnsembl integrates human pangenome data including 565 haplotypes from the Human Pangenome Reference Consortium, providing population-level genomic reference data.
- Vertebrate Genomes ProjectcoreGenome assemblies from the Vertebrate Genomes Project are regularly incorporated into Ensembl, contributing high-quality reference genomes for vertebrate species.
- European Reference Genome AtlascoreEnsembl receives genome data from the European Reference Genome Atlas project, which aims to generate reference genomes for European biodiversity.
Scale indicators6 records
Recent moves4 records
Expansion highlights4 records
Ensembl competitors and assessment
Company assessmentEmerging players
- gnomAD (Genome Aggregation Database): gnomAD provides population-level genomic variant frequency data and complements Ensembl's variant annotation tools (VEP), with partial overlap in serving clinical geneticists and pharma researchers interpreting variants at scale.
- Galaxy Project: Galaxy is an open web-based platform for accessible genomic analysis that integrates Ensembl data and tools within broader bioinformatics workflows, targeting many of the same academic and clinical research users for downstream analysis.
- UCSC Cancer Genomics Browser: UCSC Cancer Genomics Browser is an extension of the UCSC Genome Browser focused on cancer genomics visualization, overlapping with Ensembl's clinical and pharma research use cases for variant interpretation and tumor genomics.
Broad incumbents
- DNAnexus: DNAnexus is a cloud-based genomics platform serving pharma and clinical customers with broader bioinformatics workflow and data management capabilities, competing for the same translational research budget that flows toward Ensembl-anchored analysis pipelines.
Direct peers
- NCBI (National Center for Biotechnology Information): NCBI provides parallel genomic reference databases (dbSNP, GenBank, Gene, RefSeq) and a genome browser that overlaps directly with Ensembl's annotation and variant resources, serving the same academic, clinical, and pharma researcher base worldwide.
- UniProt: UniProt is a sister EMBL-EBI resource providing comprehensive protein sequence and functional annotation, often cited alongside Ensembl in the same genomics publications and integrated into the same cross-reference framework for biological research.
- UCSC Genome Browser: UCSC Genome Browser is the closest direct peer to Ensembl, offering an interactive web-based viewer for reference genomes and annotations across multiple species, with similar tools for variant visualization, BLAT sequence search, and gene-level exploration used by the same genomics research community.
Regional players
- WormBase: WormBase is a model organism genome database for C. elegans with comparable annotation, comparative genomics, and variant tools, frequently cross-referenced with Ensembl for nematode research workflows.
- Saccharomyces Genome Database (SGD): SGD is a model organism database for yeast genomics providing curated annotations and comparative tools analogous to Ensembl's Fungi division, serving a specialized research community that overlaps with Ensembl's fungal genome users.
Others
- Ensembl is part of EMBL-EBI's data portfolio alongside resources like Pfam, Rfam, and InterPro: The European Bioinformatics Institute (EMBL-EBI) hosts Ensembl alongside protein family databases (Pfam), RNA families (Rfam), and protein domain resources (InterPro), with shared infrastructure, cross-references, and overlapping research user communities.
Market position
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Ensembl social profiles
Digital presenceEnsembl financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ensembl leadership team
Management profileNumber of profiles
Ensembl subsidiaries and ownership
Company hierarchySubsidiaries5 records
Ensembl funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ensembl M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ensembl
What does Ensembl do?
Ensembl provides a free, web-based genome browser platform delivering integrated reference genomes, annotations, and analysis tools for over 4,700 species, including human, mouse, zebrafish, plants, fungi, protists, and prokaryotes. Researchers access interactive visualization, sequence similarity search (BLAST/BLAT), variant functional annotation (VEP), and data mining/export (BioMart), with both web UI and REST API access. The platform is operated by EMBL-EBI as a public research infrastructure, serving academic scientists, pharmaceutical researchers, and clinical geneticists worldwide.
Is Ensembl a public or private company?
Ensembl is a private company. It is classified as state government owned and is currently operating.
When was Ensembl founded?
Ensembl was founded in 1999. It employs 51 to 100 people.
Where is Ensembl based?
Ensembl is headquartered in Hinxton, United Kingdom, in the Europe region.
How does Ensembl make money?
One revenue line is on record: free Public Access.
Who are Ensembl's main competitors?
Emerging players on record are gnomAD (Genome Aggregation Database), Galaxy Project and UCSC Cancer Genomics Browser. DNAnexus is listed as a broad incumbent. Direct peers are NCBI (National Center for Biotechnology Information), UniProt and UCSC Genome Browser. Regional players are WormBase and Saccharomyces Genome Database (SGD). Ensembl is part of EMBL-EBI's data portfolio alongside resources like Pfam, Rfam, and InterPro is listed as an others.
Does Ensembl have an API?
Yes. Ensembl provides programmatic access to its data and tools. Important info for programmatic access is available on the Ensembl blog. This is particularly relevant for the upcoming platform transition in July 2026.
What industry is Ensembl in?
Ensembl's product category is Genomics Bioinformatics Platform. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 5132 and its SIC code is 8731.